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The outer mitochondrial membrane isoform of mammalian
cytochrome b5 (OM b5) is much less prone to lose heme than
the microsomal isoform (Mc b5), with a conserved difference
at position 71 (leucine versus serine) playing a major role.
We replaced Ser71 in Mc b5 with Leu, with the prediction
that it would retard heme loss by diminishing polypeptide
expansion accompanying rupture of the histidine to iron
bonds. The strategy was partially successful in that it slowed
dissociation of heme from its less stable orientation in
bMc b5 (B). Heme dissociation from orientation A was
accelerated to a similar extent, however, apparently owing
to increased binding pocket dynamic mobility related to
steric strain. A second mutation (L32I) guided by results
of previous comparative studies of Mc and OM b5s diminished the steric strain, but much greater relief was achieved
by replacing heme with iron deuteroporphyrin IX
(FeDPIX). Indeed, the stability of the McS71L b5 FeDPIX
complex is similar to that of the FeDPIX complex of OM
b5. The results suggest that maximizing heme binding pocket
compactness in the apo state is a useful general strategy for
increasing the stability of engineered or designed proteins.
Keywords: apoprotein/cytochrome b5/heme replacement/
mutagenesis/stability

Introduction
The two genes coding for membrane-associated isoforms of
cytochrome b5 in mammals (Lederer et al., 1983) probably
arose via duplication of a primordial gene (Guzov et al.,
1996). Subsequent functional divergence resulted in targeting
of one isoform to the membrane of the endoplasmic reticulum
(microsomal or Mc b5) and of the other to the outer mitochondrial membrane (OM b5) (Mitoma and Ito, 1992; Kuroda et al.,
1998). Mc and OM b5 are anchored to membranes of their
respective organelles by a C-terminal hydrophobic domain,
with their soluble heme-binding domains extending into solvent (Ozols, 1989; Vergeres and Waskell, 1995). Research in
our laboratories has shown that Mc and OM b5 heme-binding
domains exhibit markedly divergent biophysical properties
(Altuve et al., 2004), consistent with involvement in different
physiological processes (Vergeres and Waskell, 1995; Soucy
and Luu-The, 2002; Ogishima et al., 2003).
Storch and Daggett reported molecular dynamics (MD)
simulations showing that the heme-binding domain of
bovine Mc b5 exhibits substantial polypeptide conformational
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Fig. 1. Amino acid sequences of the recombinant bMc and rOM b5 hemebinding domains used in the present work. Residues are numbered according
to the scheme originally proposed for the lipase fragment of bMc b5 (Mathews
et al., 1979). Heme ligands His39 and His63 are shown in bold. The letters under
the rOM b5 sequence indicate residues with side chains participating in conserved OM b5 hydrophobic packing motifs a and b.

mobility (Storch and Daggett, 1995). They suggested that this
might reflect a need for adaptability in recognition of diverse
redox partners, but that it could also represent initial stages of
polypeptide unfolding. Evidence supporting a relationship
between polypeptide dynamic mobility and b5 stability has
been provided by studies in our laboratories comparing recombinant proteins representing the heme-binding domains of
bovine Mc (bMc) b5 and rat OM b5 (rOM b5) (see Figure 1).
Hydrogen–deuterium exchange (HDX) experiments monitored
by NMR spectroscopy have shown that rOM b5 exhibits dampened polypeptide dynamic mobility in comparison with bMc
b5 (Simeonov et al., 2005), confirming and extending observations in earlier MD simulations (Altuve et al., 2001; Lee and
Kuczera, 2003). In addition, OM b5s are kinetically inert with
respect to dissociation of hemin (ferric heme) at 37 C and pH 7,
conditions under which loss of hemin from Mc b5s to apomyoglobin (apoMb) is complete within a couple of days (Silchenko
et al., 2000; Altuve et al., 2004). It is reasonable to assume that
OM b5s also exhibit enhanced thermodynamic stability relative
to Mc b5s under these physiologically relevant conditions.
Providing proof of this possibility has been hampered by factors such as incomplete reversibility of unfolding reactions,
however (Cowley et al., 2002).
Mc and OM b5 heme-binding domains exhibit essentially
identical three-dimensional folds comprising two hydrophobic
cores (Rodriguez-Maranon et al., 1996), as highlighted in
Figure 2A by the X-ray crystal structure of bMc b5 (Durley
and Mathews, 1996). Heme resides in core 1, stabilized by
(1) ligation between iron and the side chains of His-39 and
His-63; (2) hydrogen bonds between Ser-64 and a heme propionate group (Lee et al., 1991; Hunter et al., 1997); and (3)
non-specific interactions between the protoporphyrin IX
(PPIX) moiety and predominantly apolar amino acid side
chains from the surrounding four-helix bundle and the core
1 side of the b-sheet. Because substituents on PPIX are asymmetrically distributed, all known b5s exist in two diastereomeric forms differing by a 180 rotation about the PPIX
a-g-meso axis. The thermodynamically dictated isomer ratio
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Fig. 2. (A) Representation of the X-ray crystal structure of bMc b5 (PDB 1CYO)
(Durley and Mathews, 1996). (B) View of the bMc b5 structure highlighting
residues involved in van der Waals contact with hemin substituents on pyrrole
rings I and II (orientation A). (C) Corresponding view of the rOM b5 crystal
structure, in which hemin was modeled in orientation A (PDB 1B5M)
(Rodriguez-Maranon et al., 1996).

is governed in significant measure by the steric environment
provided by amino acid side chains lining the base of the heme
binding pocket (Lee et al., 1990, 1991; Mortuza and Whitford,
1997; Altuve et al., 2001; Cowley et al., 2002). The orientations are designated A and B, with A dominating at equilibrium
in all known Mc b5s (A:B  9:1 in bMc b5) (McLachlan et al.,
1986). OM b5s exhibit a slight preference for hemin orientation
B (A:B = 1:1.2 in rOM b5 (Silchenko et al., 2000)). Amino acid
side chains contributing to these differences are highlighted in
Figures 2B and 2C.
Removal of heme from Mc and OM b5 causes essentially
complete disruption of secondary and tertiary structure in
core 1, but leaves core 2 and strands 1–4 of the b-sheet
with significant holo-like structure (Huntley and Strittmatter,
572

1972; Falzone et al., 1996; Falzone et al., 2001; Cowley et al.,
2004). The resulting apoproteins (bMc and rOM b5 apo-b5)
exhibit similar thermodynamic stability under physiologically
relevant conditions (Silchenko et al., 2000; Cowley et al.,
2004), in stark contrast to observations noted above for the
corresponding holoproteins. Recent studies indicated the
empty rOM apo-b5 heme binding pocket to be more compact
and less dynamically mobile than that of bMc apo-b5, however
(Cowley et al., 2004), which led to the following conclusions:
(1) the lower hemin release barriers of Mc b5s in comparison to
OM b5s results not only from more frequent conformational
changes that can trigger prosthetic group dissociation, but also
from the fact that a given triggering event will tend to be
accompanied by more extensive melting of local structure;
and (2) the apparently greater thermodynamic stability of
OM holo-b5s in comparison to Mc holo-b5s is at least partially
due to a smaller entropic penalty for polypeptide folding
associated with heme binding.
We have identified two conserved hydrophobic packing
motifs (Motifs a and b) near the core 1/core 2 interface in
OM b5s, which are more extensive than the corresponding
conserved Mc b5 interactions (Altuve et al., 2004). Residues
contributing to these different conserved interactions in rOM
and bMc b5 are highlighted in Figure 1 and some also appear in
Figures 2B and 2C. Studies in which amino acids contributing
to rOM b5 Motifs a (Altuve et al., 2001) and b (Cowley et al.,
2002) are systematically replaced by the corresponding Mc b5
residues have shown that they contribute to the higher OM b5
hemin release barriers. Replacing Motif a in its entirety via the
A18S/I32L/L47R triple mutant caused a modest decrease in
holoprotein stability, without significantly affecting apoprotein
stability. More recently we have shown that the Motif a swap
exerts little if any effect on core 2 structure or core 1 compactness in rOM apo-b5 (Cowley et al., 2005). On the other hand,
replacing Leu-71 in rOM b5 Motif b with Ser led to large
decreases in both holo- and apoprotein stability (Cowley
et al., 2002). It also resulted in a large increase in polypeptide
expansion that accompanies heme release, well beyond that
observed for bMc b5, in large part because it caused apoprotein
conformational disorder to extend beyond core 1 and into core
2 (Cowley et al., 2005).
The results of the studies described above suggested to us
that Leu-71 plays a dominant role in maintaining the empty
heme-binding pocket of OM apo-b5 in a compact state relative
to that of Mc apo-b5. As a means of probing this possibility and
testing a hypothesis that it contributes to the higher hemin
release barriers exhibited by OM holo-b5s relative to Mc
holo-b5s, we generated the S71L mutant of bMc b5. As
described in this report, the S71L mutation increased the compactness of the empty bMc apo-b5 heme-binding pocket. It also
resulted in a diminished hemin release rate constant, but only
for the isomer with hemin in orientation B. In contrast, the
S71L mutation accelerated release of hemin from orientation A.
Steric strain between hemin and the side chains of Leu-71 and
other amino acids at the base of its binding pocket as a source
for this observation was suggested by broadening of signals for
hemin substituents in 1H NMR spectra of the former. This
hypothesis was confirmed in studies comparing wild-type
bMc b5 (bMcWT b5) and its S71L mutant (bMcS71L b5) in
which hemin had been replaced by the less sterically demanding analogue deuterohemin, as well as by introduction of a
second rational mutation.

Rationally stabilizing microsomal cytochrome b5

Materials and methods

Site-directed mutagenesis
The QuikChange site-directed mutagenesis kit (Stratagene)
was used to construct the S71L and L32I/S71L mutants of
bMc b5, starting from the pET 11a plasmid harboring
(Cowley et al., 2002) the synthetic gene (Funk et al., 1990)
for the wild-type protein. The primers used to introduce
the S71L mutation were 50 -GTACCGACGCTCGTGAACTGCTGAAAACGTTCATCATCGGTG-30 (forward) and
50 -CATGGCTGCGAGCACTTGACGACTTTTGCAAGTAGTAGCCAC-30 (reverse). The primers used to introduce the
L32I mutation were 50 -GTATACGACATAACTAAATTCCTGGAAGAGCACC-30 (forward) and 50 -TTTAGTTATGTCGTATACTTTGTAGTGCAGGATCAG-30
(reverse).
The
underlined codons indicate the site at which the mutations
were introduced. The recombinant constructs were transformed
into Escherichia coli XL1 blue competent cells for amplification. Once the mutations were confirmed by gene sequencing,
the recombinant plasmids were transformed into E.coli
BL21(DE3) cells for protein expression.

Proteins
Proteins were expressed and purified as described previously
(Rivera et al., 1992), with the following changes introduced to
enhance the yield of holoprotein. (1) Expressions were performed at 27 C rather than at 37 C, as the lower temperature
has been shown to mitigate formation of inclusion bodies by
bMc apo-b5 and to generally enhance yields of holoproteins in
all cases (Cowley et al., 2004). (2) Hemin was added to the
crude supernatant to convert residual apoprotein to the holo
form (Falzone et al., 1996), followed by centrifugation to
remove excess hemin. Concentrations of holoprotein in experimental samples were estimated by electronic absorption spectroscopy, using the absorbance at 412 nm (Soret band lmax) and
an assumed extinction coefficient (e412) of 130 000 M1 cm1
(Beck von Bodman et al., 1986). Apoproteins were prepared
using the acid butanone method of Teale (Teale, 1959) and
the stock solutions were maintained at 4 C and used within
2 days of preparation. Apoprotein concentrations were
determined from the extinction coefficient at 280 nm (e280 =
11 460 M1 cm1 for bMcWT, bMcS71L and bMcL32I/S71L
apo-b5; 12 950 M1 cm1 for rOM apo-b5), calculated based
on the number of Trp and Tyr residues (Gill and von Hippel,
1989).

Table I. Data from analytical expression and DLS experiments
Protein Expression:
yields at 27 C

Holo
(mg/ml)a

Apo
(rel.)b

RH (nm)

Holo

Polydispersity
(%)
Apo

Holo

bMc
4.5 6 0.2 0.30 6 0.02 1.93 6 0.09 2.12 6 0.13 5.2
bMc
7.8 6 0.3
1.0 6 0.08 1.87 6 0.14 1.95 6 0.12 5.7
S71L
rOM
10.7 6 0.5 0.89 6 0.07 1.78 6 0.12 1.83 6 0.13 4.7

Apo

7.1
6.3
5.3

a

Determined by UV–visible spectrophotometry. Average and standard
deviation from four trials.
b
Relative; determined by densitometry. Average values and average
deviations from two trials.

inclusion bodies using an established method (De Bernardez
Clark, 1998).

Dynamic light scattering (DLS)
DLS measurements (Schmitz, 1990) were performed on a
BI-200SM research goniometer with a BI-9000AT digital correlator (Brookhaven Instruments). Incident light of l = 532 nm
(0.3–1.0 W) was used, with scattered light detected with a
photomultiplier tube at an angle of 90 . Sample temperature
was controlled by means of a thermostated cell jacket and
monitored with a thermocouple. Samples (100 mM) were
passed through 100 nm filters (Whatman) immediately before
each use. Two independent measurements were performed for
each protein, each consisting of six 30 s runs which were
averaged by the instrument software to obtain standard deviations. All data could be fitted multimodally and essentially
100% of the scattering mass was attributed to a single low
molecular mass component. The diffusion coefficient (D)
and the hydrodynamic radius (Rh) are related by the Stokes–
Einstein equation:
Rh = kT=6pZD

ð1Þ

where T is the temperature in kelvin, k is the Boltzmann constant (1.38 · 1016 erg/K) and Z is the solution viscosity (set at
1.0 and 1.663 g/cm.s for samples examined in buffered aqueous
solution and in 8 M urea, respectively, at 25 C) (Kawahara
and Tanford, 1966).

Circular dichroism (CD) spectroscopy
Analytical expression experiments
Analytical expression experiments (Cowley et al., 2004) with
rOM, bMcWT and bMcS71L bMc b5 were always performed
simultaneously using the same protocol as for preparative
runs, but with 250 ml of LB medium. IPTG was added to
each sample only when its OD600 had reached a value of
1.0 (5 h). Identical solution volumes were maintained
throughout the lysis and centrifugation steps. Actual yields
of holoproteins were calculated by electronic absorption spectroscopic analysis of supernatants, using the absorbance at
412 nm. Relative amounts of apoproteins were evaluated by
densitometric analysis of native PAGE gels (Bio-Rad Molecular Imager FX; Table I). Table I reports data obtained in
four separate trials for the holoproteins and in two separate
trials for the apoproteins. Cell pellets were analyzed for

CD spectra were recorded on a Jasco J-710 spectropolarimeter
equipped with a Jasco PTC-4235 Peltier thermostated cell
holder. A 0.2 cm flat cell was used in all cases. Far-UV
(190–250 nm) and near-UV (255–340 nm) spectra were
acquired at 1.0 nm intervals with a response time of 4 s and
a scan rate of 50 nm/min and represent the average of five
scans.

Chemical denaturation studies
All chemical denaturation experiments were performed at
25 C, with solutions buffered to pH 7.0 using 30 mM
MOPS. Denaturant stock solution concentrations were verified
from measurements of the solution refractive index. All
samples were incubated at 25 C for 1 h before spectra were
recorded. Holoprotein chemical denaturation was monitored
573
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Table II. Chemical denaturation and heme transfer data
Transfer data at 37 C, pH 7.0: k–H (h1)

Denaturation at 25 C
Holoproteins (GdmSCN)
Cm (M)
bMcWT
bMcS71L
bMcS71L/L32I
rOM

1.52
1.59
1.80
2.04

6
6
6
6

Apoproteins (GdmCl)
Cm (M)

0.02
0.03
0.02
0.08

1.78
2.30
1.90
1.27

6
6
6
6

0.07
0.04
0.02
0.03

DG

H2O

3.0
3.8
3.5
3.2

6
6
6
6

FePPIX

FeDPIX

0.28 6 0.01
0.40 6 0.02
0.084 6 0.001
–b

4.32 6 0.04
0.26 6 0.01
–a
0.12 6 0.01

(kcal/mol)
0.1
0.1
0.1
0.1

a

Not determined.
No transfer observed.

b

by electronic absorption spectroscopy using a Varian Carey
100 Bio UV–visible spectrophotometer equipped with Peltierthermostated cell holder (protein concentrations of 3–4 mM),
following the change in absorbance at 412 nm (Soret band
lmax). Apoprotein chemical denaturation was monitored by
fluorescence spectroscopy using a PTI QuantaMaster luminescence spectrometer (protein concentrations 0.5–1 mM), following changes in emission (340 nm) of Trp22 (excitation
at 295 nm). Apoprotein denaturation curves were fitted
(Kaleidagraph, v. 3.5) to the equation (Pace, 1986)
fraction folded = exp½ðDGN!U  m½DÞ=RT 
=f1 + exp½ðDGN!U  m½DÞ=RTg

ð2Þ

where DGN!U is the free energy of unfolding in the absence
of denaturant, [D] is the concentration of denaturant and m
is a parameter indicating the sensitivity of the free energy
of unfolding to denaturant concentration. The concentration
of denaturant at which each protein is 50% denatured
(Cm value) was calculated using the equation
DGN!U = Cm m

ð3Þ

Mean values and average deviations of DGN!U, Cm and
m calculated from three independent runs for each apoprotein
are reported in Table II. Because holoprotein denaturation
is not fully reversible and also appears to deviate from twostate behavior (Cowley et al., 2002), Table II reports only
mean values and average deviations of Cm obtained from
the inflection points in denaturation curves obtained in three
independent runs.

Hemin transfer studies
Horse skeletal apomyoglobin (apoMb) was employed as the
receiving protein in hemin transfer experiments. Removal of
heme from the holoprotein (Calbiochem) was accomplished
using the method of Teale (Teale, 1959). Measurements
were performed at 37 C in 150 mM potassium phosphate
solution buffered to pH 7.0, using a 20-fold excess of
apoMb. Solutions contained 450 mM sucrose to help stabilize
the apoproteins (Hargrove et al., 1994). ApoMb concentrations were estimated using an extinction coefficient of
16.0 mM1 cm1 at 280 nm (Harrison and Blout, 1965).
The absorbance at 406 nm (A406) was monitored as a function
of time and rate constants were determined by fits to a single
exponential equation.
574
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H NMR spectroscopy

All samples (1.0 mM protein) were prepared in perdeuterated
sodium phosphate buffer (m = 0.1 M, pH 7.0) to a final volume
of 500 ml; the pH values were not corrected for the isotope
effect. 1H NMR spectra were acquired on a Varian Unity spectrometer operating at 598.658 MHz (1H frequency). Spectra
were acquired with water presaturation over a 35 kHz spectral
width, using a 0.4 s acquisition time and a 1.0 s relaxation
delay.

Prosthetic group reconstitution
Experiments in which apoproteins were reconstituted with
hemin (FeIII protoporphyrin IX chloride; FePPIX) or deuterohemin (FeIII deuteroporphyrin IX chloride; FeDPIX) were
performed at 4 C. The stoichiometric amount of FePPIX or
FeDPIX that was needed was calculated with the aid of a
reconstitution experiment monitored by electronic absorption
spectroscopy. Thus, a solution of freshly prepared apoprotein
was exchanged into perdeuterated phosphate buffer (pH 7.0,
m = 0.1) and concentrated to a final volume of 500 ml
(1 mM). A small aliquot (5 ml) of this protein solution
was diluted to 500 ml with phosphate buffer in a cuvette and
titrated with a solution of FePPIX or FeDPIX obtained by
diluting a 100 ml aliquot of a stock solution (10 mg/ml in
DMSO-d6) to 300 ml with DMSO. The progress of the reconstitution was monitored by plotting the absorbance at the
Soret band lmax (412 nm for FePPIX; 402 nm for FeDPIX)
as a function of the volume of stock solution added. The
absorbance increases linearly with the addition of each aliquot
of hemin until a stoichiometric amount has been added. Further
addition of DPIX or PPIX results in a more gradual increase in
absorbance at the Soret band lmax; the inflection point in the
resulting curve was used to calculate the volume of hemin
equivalent to a 1:1 stoichiometric ratio. In reconstitutions
with DPIX, 1.0 equivalent was added and the sample was
subsequently passed through a G25 column to remove excess
DPIX. Reconstitutions with PPIX were for use in hemin isomer
equilibration studies monitored by NMR spectroscopy. In order
to avoid equilibration prior to beginning the experiments and to
limit problems due to excess hemin, 0.9 equivalent of hemin
was added to the 500 ml solution of apo-b5. Rate constants
for hemin–isomer interconversion were obtained by monitoring the time-dependent changes in the areas under the hemin
resonances corresponding to isomers A and B as described
previously (LaMar et al., 1984; Walker et al., 1988). The
equilibrium constant was obtained from an NMR spectrum
recorded after the isomer ratio had reached a constant value.

Rationally stabilizing microsomal cytochrome b5

Results and discussion

Effect of heme binding pocket compactness on
polypeptide expression
The synthetic genes coding for the rOM (Rivera et al., 1992)
and bMcWT b5 (Funk et al., 1990) polypeptides used in our
studies (see amino acid sequences in Figure 1) are both under
control of the strong T7 promoter in pET11a (Cowley et al.,
2002). We have observed that bMcWT and rOM b5 polypeptide
production in E.coli BL21(DE3) cells outpaces heme incorporation (Cowley et al., 2004), as previously reported for rat
Mc b5 using a similar expression system (Falzone et al., 1996).
The holo and apo forms of the two proteins in supernatants
obtained after expression and cell lysis can be observed by
native PAGE (Figure 3). Despite the use of analogous expression systems, rOM holo-b5 and apo-b5 are reproducibly
obtained in at least 3-fold greater yield than the corresponding
forms of bMcWT b5 when expressions are performed at 27 C
(Table I), a temperature at which neither protein forms
inclusion bodies (Cowley et al., 2004).
Replacing Ser71 with Leu in bMcWT b5 substantially
increases holoprotein production at 27 C and results in an
increased level of apoprotein present in crude supernatants
(Figure 3, Table I). In fact, the total yield of bMcS71L b5 polypeptide (holo plus apo) is similar to that observed for rOM b5
using identical expression conditions (Figure 3; Table I). In
addition, the native PAGE data in Figure 3 show that bMcS71L
apo-b5 migrates more rapidly than bMcWT apo-b5, consistent
with our hypothesis that the S71L mutation would increase
the compactness of the empty bMcWT apo-b5 heme-binding
pocket. The S71L mutant apoprotein even migrates somewhat

faster than rOM apo-b5, probably reflecting its smaller net
negative charge (theoretical pI = 4.94 vs 4.62 for rOM
apo-b5) rather than greater compactness of its binding pocket.
Consistent with this interpretation, DLS data (Figure 4; Table I)
show that removal of heme from bMcS71L apo-b5 results in a
much smaller increase in hydrodynamic radius (4.3%) than
observed for bMcWT b5 (9.8%), but still larger than occurs
for rOM b5 (2.8%) (Cowley et al., 2004). It is noteworthy
that bMcS71L apo-b5 also exhibits a polydispersity value
(6.3%) midway between those of bMcWT (7.3%) and rOM
apo-b5 (5.3%), suggesting an inverse correlation between
core 1 compactness and the number of conformational states
that it can explore. It is interesting to speculate that the large
and highly reproducible increase in bMc b5 polypeptide production in our E.coli expression system resulting from the
S71L mutation is related to the increase in heme-binding compactness indicated by the native-PAGE and DLS data. Perhaps
increasing the compactness of structurally disordered core 1
protects it against proteolytic degradation.
Enhanced compactness of bMcS71L apo-b5 relative to
bMcWT apo-b5 is not associated with an increase in secondary
structure, as we observe no change in the far-UV CD spectra
(data not shown). The near-UV CD spectra of wild-type and
bMcS71L apo-b5 are also virtually identical, indicating no
change in tertiary structure. These observations are consistent
with the fact that the mutation involves a residue in core 1,
which is largely devoid of regular secondary structure to begin
with and therefore also lacks organized packing in the vicinity
of aromatic side chains located in that region.

The S71L mutation inverts the relative stabilities of
hemin orientations A and B

Apo
Holo
rOM bMc S71L rOM bMc S71L
Fig. 3. Native PAGE data for bMcWT, bMcS71L and rOMWT b5. Lanes 1–3,
purified apoproteins; lanes 4–6, supernatants from analytical expressions.

bMc

100

WT

The potential impact of the S71L mutation on bMcWT apo-b5
thermodynamic stability at 25 C and pH 7 was probed in
guanidinium chloride (GdmCl)-mediated denaturation studies,
monitored by fluorescence spectroscopy (Figure S1A, Supplementary data available at PEDS Online). Unfolding free energies for bMcWT and bMcS71L apo-b5 in the absence of GdmCl
(DGN!U values), extrapolated from fits of the denaturation
data to a two-state equation (Equation 2), are compiled in
Table II. Table II also reports the concentration of GdmCl
at which each apoprotein is 50% unfolded (Cm value), as
well as DGN!U and Cm values previously reported for
GdmCl-mediated denaturation of rOM apo-b5 (Cowley et al.,
2002). Analogous studies with the holoproteins utilizing the
more powerful denaturant GdmSCN were monitored by

S71L
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rOM
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Fig. 4. Size distribution plots comparing DLS data for the holo (solid lines) and apo (dashed lines) forms of bMc

b5 (left), bMcS71L b5 (center) and rOMWT b5 (right).
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UV–visible spectrophotometry (Figure S1B; Table II). Because
holo-b5 unfolding reactions are not fully reversible and tend to
deviate from two-state behavior (Cowley et al., 2002), Table II
only reports approximate Cm values for the holoproteins.
The S71L mutation led to a small increase in the Cm value of
bMcWT holo-b5 (from 1.52 to 1.59 M GdmSCN), suggesting
perhaps some increase in stability in the absence of denaturant.
The mutation led to a considerably larger increase in the Cm
value of the corresponding apoprotein (from 1.78 to 2.30 M
GdmCl) and increased the unfolding free energy of bMcWT
apo-b5 in the absence of denaturant by 0.8 kcal/mol. It is
important to emphasize that the difference in unfolding free
energies of bMcS71L and bMcWT apo-b5 becomes larger with
increasing [GdmCl]. Because holo-b5 stability is strongly
dependent on apoprotein stability, this finding suggests that
bMcS71L holo-b5 may actually be less stable than bMcWT b5
in the absence of denaturant. At the very least, the chemical
denaturation data show that replacing Ser71 in bMcWT
holo-b5 with Leu did not lead to a large increase in holoprotein
stability.
The 1H NMR spectra of b5s exhibit paramagnetically shifted
signals for several hemin substituent protons. Published assignments (Walker et al., 1988) for hemin substituent signals in
both its more stable (A) and less stable (B) orientations in
bMcWT b5 (the isomers are referred to hereafter as bMcWT,A
and bMcWT,B b5, respectively) allowed ready assignment of
many of the corresponding signals in the spectrum of the S71L
mutant. 1H NMR spectra of bMcWT and bMcS71L b5 recorded
after the ratio of hemin isomers had reached a constant value at

Table III. Data from NMR experiments
Protein

bMcWT
bMcS71L
bMcS71L/L32I
rOM
a

A:B (equil.)

8.2:1
1:8.2
1:1.4
1.2:1

Not determined.
Too slow to measure.

b

km!M (h1)

0.081
0.10
–a
–b

kM!m (h1)

0.010
0.013
–a
–b

Linewidth (Hz)
A5Me

B3Me

44.8
70.2
43.8
37.4

46.9
48.6
47.2
42.8

24 C show a complete reversal of hemin binding selectivity:
from A:B  8:1 in bMcWT b5 to A:B  1:8 in bMcS71L b5
(Table III; Figure S2).
For the purpose of examining the effect of the S71L mutation
on the kinetic barrier for hemin release, bMcWT and bMcS71L
apo-b5 were reconstituted with hemin at 4 C. As expected on
the basis of previously reported studies (McLachlan et al.,
1986; Walker et al., 1988), the 1H NMR spectra of each protein
recorded at 4 C immediately after reconstitution showed that
hemin orientations A and B were present in an 1:1 ratio. No
change in this ratio was observed to occur at 4 C over a 24 h
period. Rate constants for conversion of the less stable (minor;
m) to the more stable (major, M) orientation (km!M) were
determined at 24 C in time-dependent NMR experiments
using an established method (LaMar et al., 1981; Walker
et al., 1988) (Figure 5; Table III).
km!M
m !
 M
kM!m
From the equilibrium orientation ratio (Keq = [M]/[m] =
km!M/kM!m), we calculated the corresponding rate constant
for the reverse reaction (kM!m). The data show that the S71L
mutation has modestly increased both km!M and kM!m.
We next compared rate constants for hemin transfer (k–H)
from bMcWT and bMcS71L b5 to excess apoMb at 37 C and
pH 7. Fits of kinetic curves for the reactions (Figure 6A;
Table II) again show that bMcS71L b5 is more prone to
hemin loss than is bMcWT b5. The hemin transfer studies
were performed with samples containing the equilibrium
ratio of A and B hemin orientations and k–H is therefore predominantly governed by loss of the major (more stable orientation) in each case (A in bMcWT b5; B in bMcS71L b5). The
combined hemin transfer and hemin isomer equilibration data
allow us to conclude that (1) hemin is released considerably
more rapidly from bMcS71L,A b5 than from bMcWT,A b5 and
even somewhat faster than from bMcWT,B b5; and (2) hemin is
released more slowly from bMcS71L,B b5 than from bMcWT,B
b5, but still somewhat faster than from bMcWT,A b5. In other
words, replacing Ser71 in bMcWT b5 with Leu has lowered
the kinetic barrier for release of hemin from orientation A, but
has enhanced the kinetic barrier for release of hemin from

Fig. 5. Plots illustrating time-dependent changes in hemin isomer ratio for bMcWT b5 (A) and bMcS71L b5 (B) at 24 C. Lines through the data points represent fits to a
monoexponential equation (see Table III).
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Fig. 6. Comparison of hemin transfer data recorded at 37 C and pH 7.
(A) FePPIX complexes of bMcWT, bMcS71L and bMcL32I/S71L b5. (B) FeDPIX
complexes of bMcWT, bMcS71L and rOM b5.

orientation B to a similar extent. In this sense, our approach
has been partially successful.
In the light of the above discussion, it is noteworthy that the
linewidths for all observable hemin substituent signals in
bMcS71L,A b5 are substantially broadened in comparison
with those for bMcS71L,B b5, as highlighted for the 5-methyl
group (A5Me) in Figure 7A and Table III. In contrast, linewidths for hemin substituents in bMcS71L,B and bMcWT,B b5 are
nearly identical, as shown for the 3-methyl group (B3Me) in
Figure 7B and Table III. The data shown were recorded at
24 C, a temperature at which we have shown hemin orientational isomer equilibration to occur. The broadening of hemin
signals in bMcS71L,A b5 relative to bMcS71L,B b5 is also present
and equally significant in spectra recorded at 4 C, however,
indicating that it is not a result of the exchange process itself.
A common source of linewidth broadening in NMR spectra is
interconversion between two or more conformational states
with rate constants similar to the chemical shift difference
(in Hz) for nuclei in those states (Sandström, 1982). The broadening of NMR signals for hemin in bMcS71L,A b5 relative to
bMcWT,A b5 could therefore reflect enhanced mobility of the
prosthetic group within its binding pocket and/or increased
dynamic motion of the surrounding polypeptide. Either of
these factors could be expected to compromise holoprotein
stability, as we have observed. The linewidth data suggest at
most a minor adverse effect of the S71L mutation on hemin
and/or polypeptide dynamics in bMcWT,B b5. Hence, the
increase in kinetic barrier for release of hemin from bMcWT,B
b5 resulting from the S71L mutation indicated in hemin transfer

31.6 31.2 30.8
ppm
Fig. 7. Signals for the A5Me (A) and B3Me (B) hemin substituents in NMR
spectra of bMcWT b5 (top), bMcS71L b5 (middle) and bMcL32I/S71L b5 (bottom),
normalized for peak height. Figure S2 (supporting information) compares the
high-frequency regions of the original spectra, which were acquired at 24 C
after the equilibrium ratio of hemin orientations had been reached.

and hemin isomer equilibration studies is probably not due to a
decrease in frequency of conformational fluctuations that can
trigger prosthetic group release. Indeed, linewidths for hemin
substituents in bMcWT,B b5 are not particularly broadened
relative to those for bMcWT,A, suggesting that the lower stability of the former is not due to adverse effects on core 1
dynamic properties. Rather, on the basis of our native-PAGE
and DLS data, we propose that the increase in the kinetic
barrier for release of hemin from bMcWT,B b5 resulting from
the S71L mutation is due to a decrease in the extent of core 1
‘opening’ that accompanies initial dissociation of hemin,
which favors faster rebinding. This is another indication that
our strategy for stabilizing bMcWT b5 has been at least partially
successful. The same factor can be expected to mask the true
impact of the S71L mutation on the kinetic barrier for release of
hemin from bMcWT,A b5.

The importance of steric complementarity between
heme and its binding pocket
A major factor contributing to the large preference for hemin
orientation A in bMcWT b5 is a hydrophobic grouping of amino
acid side chains from b4 (Leu23; Leu25) and b5 (Ala54) (see
Figure 2B). The side chains of these three amino acids create
a steric environment accommodating the 3-methyl group of
pyrrole ring II in bMcWT,A b5 (A3Me) better than the corresponding 2-vinyl group of pyrrole ring I in bMcWT,B b5 (B2V).
The environment near the 2-vinyl group of pyrrole ring I
in bMcWT,A b5 (A2V) is much less sterically congested.
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The hydrophobic side chain of Leu32 makes van der Waals
contact with A2V from below (with the protein oriented as
in Figure 2B), while the much smaller side chain of Ser71
makes contact with the same group from above.
The small preference for hemin orientation B relative to A
exhibited by rOM b5 has been attributed to the presence of Leu
at position 71 (see Figure 2C), which decreases the space
available for a nearby A2V group in rOMA b5 (Altuve et al.,
2001). Consistent with this argument, replacing Leu71 in rOM
b5 with Ser has been shown to change the equilibrium hemin
orientation ratio from A:B = 1:1.2 to 5.2:1 (Cowley et al.,
2002). The complete reversal of the equilibrium hemin orientational ratio in bMcWT b5 resulting from the S71L mutation
can therefore also be attributed to an increase in steric crowding that has a more adverse affect on the ability of the 2V group
to fit comfortably (in bMcS71L,A) than it does on the smaller
3-methyl group when heme is present in orientation B
(in bMcS71L,B).
As an initial approach for probing our hypothesis that steric
strain between heme and its binding pocket contributes to
destabilizing dynamic mobility in S71L bMc b5, we removed
hemin (FePPIX) and replaced it with deuterohemin (FeIII deuteroporphyrin IX; FeDPIX). FeDPIX differs from FePPIX in
having hydrogen atoms rather than vinyl groups at positions 2
and 4. Replacing FePPIX in wild-type bMc b5 with FeDPIX
has previously been shown to cause a large increase in the rate
at which hemin orientations A and B reach equilibrium starting
from an 1:1 ratio (McLachlan et al., 1986). Consistent with
that report, our studies show that FeDPIX is lost from bMcWT
b5 to apoMb 15-fold more rapidly than is FePPIX (Figure 6;
Table II). The corresponding replacement in rOM b5 also lowered the barrier for prosthetic group release, but the extent of
the effect could not be quantified. In contrast, the kinetic barrier
for prosthetic group release from bMcS71L b5 increased when
FePPIX was replaced by FeDPIX. In fact, the rate constant for
prosthetic group loss from the FeDPIX complex of bMcS71L b5
is 16-fold smaller than that for the FeDPIX complex of bMcWT
b5 and only about 2-fold greater than that exhibited by the
FeDPIX complex of rOM b5.
Identification of the most likely source of steric strain in the
FePPIX complex of bMcS71L b5 was informed by our previous
studies in which residues contributing to conserved hydrophobic packing motifs a and b in rOM b5 were replaced with the
corresponding bMc b5 residues (Altuve et al., 2001; Cowley
et al., 2002). Replacing Ile25 in motif b of rOMWT b5 with Leu
barely altered the A:B ratio, nor did it significantly affect hemin
release kinetics (Cowley et al., 2002). In contrast, replacing
Ile32 in motif a of rOMWT b5 with Leu led to an increase in
relative stability of orientation A (from A:B = 1:1.2 to 4:1) and
markedly accelerated both hemin orientational isomer equilibration and hemin transfer (Altuve et al., 2001). This can be
attributed to the fact, noted above, that the side chains of
residues 71 and 32 impinge upon the 2-vinyl group from
above and below the mean plane of the prosthetic group in
orientation A. The presence of two d-methyl groups on Leu as
opposed to one in Ile significantly increases steric crowding
near the A2V group when residue 71 is also a Leu.
To probe the hypothesis that the presence of Leu at positions
71 and 32 is a major source of steric strain in bMcS71L b5, we
generated the L32I/S71L double mutant (bMcL32I/S71L b5). The
S71L and L32I/S71L mutants exhibit similar unfolding free
energies at 25 C as determined in GdmCl-mediated
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denaturation studies (Figure S1A; Table II), consistent with
the conservative nature of the second mutation. However,
the L32I mutation significantly increases the holoprotein Cm
value (Figure S1B; Table II), rendering it much more OM b5like and suggesting an increase in the kinetic barrier for hemin
release. The latter was verified in hemin transfer
studies performed at 37 C and pH 7, which show that
bMcL32I/S71L b5 loses hemin 5-fold more slowly than does
bMcS71L b5 and 3-fold more slowly than does bMcWT b5
(Figure 6A; Table II). The effect is considerably smaller
than observed upon replacement of FePPIX with FeDPIX
in bMcWT and bMcS71L b5, but nonetheless suggests that we
correctly identified a key source of the steric strain between
hemin and the polypeptide in the S71L mutant.
Table III shows that introducing the L32I mutation into
bMcS71L b5 substantially increases the population of hemin
orientation A relative to orientation B as determined by
NMR, from A:B = 1:8 (Figure S2B) to 1.4:1 (Figure S2C).
In fact, the equilibrium ratio of hemin orientations in
bMcL32I/S71L b5 is very close to that exhibited by rOM b5
(A:B = 1:1.2; Figure S2D). In addition, the linewidths for
hemin isomer A substituents in bMcL32I/S71L b5 are greatly
narrowed in comparison with their counterparts in the spectrum
of bMcS71L b5 (Figure 7A; Table III). We interpret these findings as indicating that the L32I mutation has primarily
increased the hemin release kinetic barrier in bMcS71L,A b5,
by damping dynamic motion in the heme binding pocket. It is
noteworthy that the A5Me linewidth for bMcL32I/S71L b5 is
narrower than the corresponding signal in bMcWT b5, but
remains broad in comparison with the signal for A5Me in
the spectrum of rOM b5. Hence the stability and linewidth
studies agree in indicating that bMcL32I/S71L b5 exhibits stability and dynamic properties midway between those of bMcWT
and rOM b5. We tentatively conclude that heme and the surrounding polypeptide in core 2 of bMcL32I/S71L b5 still suffers
from steric strain in comparison with rOM b5, allowing more
frequent, albeit less extensive, conformational changes that
can trigger release of the prosthetic group.

Conclusion
Our studies suggest that heme-binding pocket compactness and
dynamic mobility in the apo state of b5 can be varied over a
wide range by shifting the balance of hydrophobic and hydrophilic residues in core 1. As demonstrated most convincingly
by the FeDPIX complexes of bMcWT and bMcS71L bMc b5,
increased binding pocket compactness can substantially retard
the rate at which hemin is released and thereby enhance holoprotein thermodynamic stability. Hence we believe that our
studies provide new general principles that can be applied
toward the design of b-heme proteins exhibiting improved
stability properties, perhaps for use in biotechnological applications. Our strategy of enhancing Mc b5 stability via reduction
in core 1 size and dynamic mobility in the apo state has its roots
in the preorganization principle enunciated by Cram (Cram,
1988) and complements previously published approaches that
focus on the holo state including (1) introduction of a disulfide
linkage that bridges cores 1 and 2 (Storch et al., 1999a,b);
(2) engineering a covalent linkage between heme and the
polypeptide (Barker et al., 1993; Lin et al., 2005); and (3)
improving core 1 secondary structure stability in the holo
state by replacing residues in helices with others having greater
helical propensity or by relieving electrostatic repulsion
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(Mukhopadhyay and Lecomte, 2004). Our strategy nonetheless
requires attention to the holo state in order to avoid introducing
steric bulk that prevents heme from seating comfortably in its
binding pocket. Finally, our studies suggest that hemin substituent linewidths are sensitive indicators of steric strain.
Hence, comparison of linewidths can nicely complement
hemin transfer and hemin orientational equilibration data as
approaches for quickly assessing effects of mutations on heme
binding properties. MD simulations and HDX experiments
monitored by NMR spectroscopy will allow us to investigate
the detailed structural basis for interesting cases and to further
our understanding of the relationship between dynamics and
stability in heme proteins and their possible involvement in
function.
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